Marc Scherlinger, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 18 | 2024 | 2104 | 4.050 |
Why?
|
Antirheumatic Agents | 8 | 2023 | 1339 | 2.090 |
Why?
|
Autoimmunity | 6 | 2024 | 1349 | 1.350 |
Why?
|
Arthritis, Rheumatoid | 8 | 2021 | 3712 | 1.300 |
Why?
|
Autoimmune Diseases | 6 | 2023 | 2133 | 1.230 |
Why?
|
Scleroderma, Systemic | 3 | 2020 | 323 | 1.200 |
Why?
|
Blood Platelets | 5 | 2023 | 2508 | 1.190 |
Why?
|
Drug Substitution | 3 | 2018 | 281 | 1.140 |
Why?
|
Arthritis | 2 | 2021 | 659 | 0.930 |
Why?
|
Phosphofructokinases | 1 | 2022 | 7 | 0.900 |
Why?
|
Antiphospholipid Syndrome | 1 | 2023 | 173 | 0.800 |
Why?
|
Aspartic Acid | 1 | 2021 | 576 | 0.680 |
Why?
|
Serum Sickness | 1 | 2017 | 28 | 0.620 |
Why?
|
Education, Graduate | 1 | 2018 | 81 | 0.610 |
Why?
|
France | 7 | 2021 | 517 | 0.600 |
Why?
|
Academies and Institutes | 1 | 2018 | 317 | 0.540 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2022 | 2988 | 0.530 |
Why?
|
Rheumatic Diseases | 2 | 2023 | 592 | 0.530 |
Why?
|
Finger Joint | 1 | 2016 | 108 | 0.530 |
Why?
|
Cell-Derived Microparticles | 1 | 2017 | 168 | 0.530 |
Why?
|
Internationality | 1 | 2020 | 1003 | 0.480 |
Why?
|
Autoantibodies | 1 | 2021 | 2035 | 0.430 |
Why?
|
Cytomegalovirus Infections | 1 | 2017 | 820 | 0.370 |
Why?
|
Cause of Death | 1 | 2020 | 3584 | 0.350 |
Why?
|
Platelet Activation | 2 | 2023 | 673 | 0.340 |
Why?
|
Thrombosis | 1 | 2023 | 2968 | 0.330 |
Why?
|
Severity of Illness Index | 4 | 2019 | 15540 | 0.290 |
Why?
|
Education, Medical | 1 | 2018 | 1721 | 0.280 |
Why?
|
Societies, Medical | 1 | 2018 | 3743 | 0.270 |
Why?
|
Biomedical Research | 2 | 2020 | 3309 | 0.270 |
Why?
|
Antibodies, Monoclonal | 4 | 2023 | 9274 | 0.270 |
Why?
|
Premature Birth | 1 | 2018 | 1721 | 0.270 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3022 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.230 |
Why?
|
Humans | 38 | 2024 | 744343 | 0.230 |
Why?
|
Glutaminase | 1 | 2022 | 35 | 0.210 |
Why?
|
Sirtuin 2 | 1 | 2022 | 97 | 0.210 |
Why?
|
Mice | 9 | 2024 | 81183 | 0.200 |
Why?
|
Biological Products | 2 | 2023 | 860 | 0.200 |
Why?
|
Selectins | 1 | 2021 | 102 | 0.200 |
Why?
|
Interleukin-2 | 3 | 2022 | 1904 | 0.190 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2024 | 986 | 0.190 |
Why?
|
Rheumatoid Factor | 1 | 2021 | 188 | 0.190 |
Why?
|
Arthritis, Experimental | 1 | 2023 | 291 | 0.190 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2020 | 26 | 0.180 |
Why?
|
Neurotransmitter Agents | 1 | 2023 | 647 | 0.170 |
Why?
|
Receptors, OX40 | 1 | 2018 | 43 | 0.170 |
Why?
|
OX40 Ligand | 1 | 2018 | 51 | 0.170 |
Why?
|
Education, Pharmacy, Graduate | 1 | 2018 | 9 | 0.160 |
Why?
|
Consensus | 2 | 2018 | 2959 | 0.160 |
Why?
|
Students, Pharmacy | 1 | 2018 | 17 | 0.160 |
Why?
|
Borrelia | 1 | 2018 | 67 | 0.160 |
Why?
|
Sjogren's Syndrome | 1 | 2020 | 233 | 0.160 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2018 | 69 | 0.160 |
Why?
|
Raynaud Disease | 1 | 2018 | 74 | 0.150 |
Why?
|
Spondylarthritis | 1 | 2018 | 62 | 0.150 |
Why?
|
Animals | 11 | 2024 | 168757 | 0.150 |
Why?
|
Myositis | 1 | 2020 | 251 | 0.150 |
Why?
|
Spondylitis, Ankylosing | 1 | 2018 | 156 | 0.150 |
Why?
|
Reactive Oxygen Species | 2 | 2022 | 2077 | 0.150 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.140 |
Why?
|
Ascorbic Acid | 1 | 2020 | 651 | 0.140 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2291 | 0.140 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2020 | 220 | 0.140 |
Why?
|
Synovial Fluid | 1 | 2018 | 394 | 0.140 |
Why?
|
Antigen-Antibody Complex | 1 | 2018 | 517 | 0.140 |
Why?
|
Interleukin-17 | 1 | 2022 | 899 | 0.140 |
Why?
|
Herpesvirus 3, Human | 1 | 2017 | 204 | 0.130 |
Why?
|
Osteogenesis | 1 | 2023 | 1299 | 0.130 |
Why?
|
Bone Diseases | 1 | 2019 | 416 | 0.130 |
Why?
|
Career Choice | 2 | 2020 | 744 | 0.130 |
Why?
|
Biological Factors | 1 | 2016 | 164 | 0.130 |
Why?
|
Methotrexate | 2 | 2019 | 1727 | 0.120 |
Why?
|
Syndrome | 1 | 2020 | 3251 | 0.120 |
Why?
|
Antioxidants | 1 | 2022 | 1663 | 0.120 |
Why?
|
Immunoglobulin E | 1 | 2020 | 1463 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2019 | 506 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 2007 | 0.110 |
Why?
|
Inflammation | 2 | 2023 | 10638 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1782 | 0.110 |
Why?
|
Prednisone | 1 | 2017 | 1574 | 0.110 |
Why?
|
Treatment Failure | 1 | 2019 | 2618 | 0.110 |
Why?
|
Lyme Disease | 1 | 2018 | 621 | 0.110 |
Why?
|
Cytomegalovirus | 1 | 2017 | 732 | 0.110 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4560 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1041 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3176 | 0.100 |
Why?
|
Patient Preference | 1 | 2018 | 890 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6489 | 0.100 |
Why?
|
Immunotherapy | 2 | 2023 | 4445 | 0.090 |
Why?
|
Prognosis | 3 | 2020 | 29063 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2576 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4665 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2024 | 11483 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4386 | 0.090 |
Why?
|
Treatment Outcome | 5 | 2019 | 63114 | 0.080 |
Why?
|
Mitochondria | 1 | 2021 | 3520 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4189 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 2958 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2019 | 3474 | 0.080 |
Why?
|
Risk Assessment | 3 | 2019 | 23338 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2684 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2063 | 0.070 |
Why?
|
Th17 Cells | 2 | 2023 | 766 | 0.070 |
Why?
|
Stress, Psychological | 1 | 2021 | 4245 | 0.070 |
Why?
|
Female | 9 | 2021 | 380194 | 0.060 |
Why?
|
Students, Medical | 1 | 2018 | 1862 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 7023 | 0.060 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21827 | 0.060 |
Why?
|
Melanoma | 1 | 2022 | 5510 | 0.060 |
Why?
|
Male | 8 | 2021 | 350118 | 0.060 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.060 |
Why?
|
Prospective Studies | 2 | 2018 | 53288 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.060 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2023 | 73 | 0.050 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2022 | 159 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9959 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18370 | 0.050 |
Why?
|
Drugs, Investigational | 1 | 2023 | 214 | 0.050 |
Why?
|
Protein Phosphatase 2 | 1 | 2022 | 229 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 401 | 0.040 |
Why?
|
Receptors, Pattern Recognition | 1 | 2020 | 78 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2020 | 393 | 0.040 |
Why?
|
Adult | 5 | 2021 | 214055 | 0.040 |
Why?
|
Ubiquinone | 1 | 2020 | 188 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 1085 | 0.040 |
Why?
|
Guinea Pigs | 1 | 2020 | 1386 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2020 | 2725 | 0.040 |
Why?
|
Complement System Proteins | 1 | 2020 | 795 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2020 | 592 | 0.040 |
Why?
|
Pregnancy | 1 | 2018 | 29144 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7322 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2019 | 412 | 0.030 |
Why?
|
Biological Therapy | 1 | 2016 | 138 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2018 | 973 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 40561 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2022 | 10481 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39050 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1641 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2018 | 810 | 0.030 |
Why?
|
Young Adult | 2 | 2018 | 56430 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 35421 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2019 | 77449 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2018 | 1607 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.020 |
Why?
|
Cell Lineage | 1 | 2020 | 2504 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4204 | 0.020 |
Why?
|
Erythrocytes | 1 | 2020 | 2455 | 0.020 |
Why?
|
Students | 1 | 2020 | 1654 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2019 | 2107 | 0.020 |
Why?
|
Calcium | 1 | 2023 | 5756 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6171 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5524 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15997 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11366 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13989 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10180 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
Child | 1 | 2018 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85781 | 0.010 |
Why?
|
Aged | 1 | 2018 | 163280 | 0.000 |
Why?
|